| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―22 |
Tunneling nanotube-mediated intercellular spread of SARS-CoV-2 variants in epithelial cells reveals a host-targeted antiviral vulnerability |
Gurleen Kaur, Ritika Khatri, Varun Kumar, Bharat Lohiya, Akanksha Chauhan, Sweety Samal |
| 2 |
[GO] |
2024―Oct―22 |
Retraction notice to “Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein” [Int. J. Biochem. Cell Biol. 38 (2006) 1417-1428] |
Xiaohong Yan, Qian Hao, Yongxin Mu, Khalid Amine Timani, Linbai Ye, Ying Zhu, Jianguo Wu |
| 3 |
[GO] |
2024―Jan―11 |
THE ROLE OF α7 NICOTINIC ACETYLCHOLINE RECEPTORS IN POST-ACUTE SEQUELAE OF COVID-19 |
Maryna Skok |
| 4 |
[GO] |
2022―Feb―24 |
Viroporins: structure, function, and their role in the life cycle of SARS-CoV-2 |
Ulrike Breitinger, Noha S. Farag, Heinrich Sticht, Hans-Georg Breitinger |
| 5 |
[GO] |
2021―Nov―05 |
Clinical features and mechanistic insights into drug repurposing for combating COVID-19. |
Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, Kielan Darcy McAlinden, Greg Haug, Matt D Johansen, Philip M Hansbro, Katie L Flanagan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal |
|
